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Edited by Richard MaraisAbstract It has been reported that S-adenosylmethionine-
dependent protein methylation in rat kidney extracts can be
greatly stimulated by tyrphostin A25, a tyrosine kinase inhibitor.
We have investigated the nature of this stimulation. We ﬁnd that
addition of tyrphostin A25, in combination with the protein
phosphatase inhibitor vanadate, leads to the stimulation of
methylation of polypeptides of 64, 42, 40, 36, 31, and 15 kDa in
cytosolic extracts of mouse kidney. The eﬀect of tyrphostin
appears to be relatively speciﬁc for the A25 species. The
enhanced methylation does not represent the activity of the
families of protein histidine, lysine or arginine methyltransfe-
rases, nor that of the L-isoaspartyl/D-aspartyl methyltransferase,
enzymes responsible for the bulk of protein methylation in most
cell types. Chemical and enzymatic analyses of the methylated
polypeptides suggest that the methyl group is in an ester linkage
to the protein. In heart extracts, we ﬁnd a similar situation but
here the stimulation of methylation is not dependent upon
vanadate and an additional 18 kDa methylated species is found.
In contrast, little or no stimulation of methylation is found in
brain or testis extracts. This work provides evidence for a novel
type of protein carboxyl methylation reaction that may play a
role in signaling reactions in certain mammalian tissues.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Enzymatic protein methylation reactions can be used by cells
to expand the functional and structural diversity of the 20
amino acids used in ribosomal protein synthesis and to mod-
ulate their activity [1]. Of special interest in understanding
regulatory processes are potentially reversible reactions in
which S-adenosyl-L-methionine is used as the methyl donor to
form protein methyl esters. Four distinct classes of these car-
boxyl methyltransferases, distinguished by the amino acid
residue that they modify, have been described to date, and
have been shown to play signiﬁcant roles in cell signaling and
in aging. For example, two types of enzymes modify normal
amino acid residues in signaling proteins. In chemotactic* Corresponding author. Fax: +1-310-825-1968.
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Abbreviations: DMSO, dimethyl sulfoxide; AdoMet, S-adenosyl-L-
methionine; [3H]AdoMet, S-adenosyl-[methyl-3H]-L-methionine
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doi:10.1016/j.febslet.2004.09.080bacteria, the CheR methyltransferase catalyzes the formation
of L-glutamyl c-methyl esters on speciﬁc membrane chemore-
ceptors to control the processing of sensory input [2]. In eu-
caryotic cells, a distinct enzyme methyl esteriﬁes the a-carboxyl
group of the C-terminal leucine residue of the catalytic subunit
of protein phosphatase 2A, modulating its interaction with
regulatory subunits [3,4]. In both of these cases, speciﬁc
methylesterases have been described that catalyze the reversal
of the methylation reaction and the return to the unmodiﬁed
residue [5,6]. A third type of enzyme, the isoprenylcysteine
methyltransferase, modiﬁes the a-carboxyl group of a lipidated
C-terminal cysteine residue on a variety of eucaryotic signaling
proteins, but this reaction does not appear to be readily re-
versible in vivo [7,8]. The last type of enzyme, the L-isoas-
partyl/D-aspartyl protein methyltransferase, recognizes
spontaneously age-damaged proteins as the ﬁrst step of a
protein repair reaction and is widely distributed in eucaryotic
and procaryotic cells [9].
Evidence has been presented for several additional types of
protein carboxyl methylation reactions but the enzymes that
catalyze these reactions have not yet been identiﬁed. For ex-
ample, the a-carboxyl group of the C-terminal lysine residue of
eucaryotic elongation factor 1A has been shown to be
methylated in yeast [10]. The Rab3D small GTPase involved in
regulated exocytosis has been reported to be modiﬁed by an
enzyme that is inhibited by N-acetyl-S-geranylgeranyl-L-
cysteine but not N-acetyl-S-farnesyl-L-cysteine, a known in-
hibitor of the isoprenylcysteine carboxyl methyltransferase
[11]. The b subunit of the xENaC protein component of the
sodium channel complex is carboxyl methylated in response
to aldosterone in a reaction that has not been chemically
characterized [12].
As part of a study on the eﬀect of nucleotides on the L-
isoaspartyl/D-aspartyl methyltransferase, tyrphostin A25 was
found to stimulate the in vitro methylation of several poly-
peptides in rat kidney cytosol [13]. Tyrphostins are a class of
synthetic low molecular weight antiproliferative compounds
that act as protein tyrosine kinase blockers, and the A25
compound is especially active against the EGF receptor kinase
[14,15]. It was hypothesized that tyrphostin A25 acts by sta-
bilizing the methyl ester groups on the substrates of the iso-
aspartyl methyltransferase [13]. Here, we show that tyrphostin
A25 addition to a mouse kidney soluble extract greatly stim-
ulates methylation of a distinct set of polypeptides but only in
the presence of the protein phosphatase inhibitor vanadate.
However, we demonstrate that tyrphostin does not aﬀect the
methylation of substrates of the isoaspartyl methyltransferase.
In addition, tyrphostin and vanadate do not aﬀect arginine,ation of European Biochemical Societies.
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present evidence that these agents stimulate the methyl ester-
iﬁcation of polypeptides via what appears to be a novel
modiﬁcation pathway.2. Materials and methods
2.1. Chemicals
A stock solution of vanadate was prepared from sodium ortho-
vanadate (Calbiochem, #567540) by suspending the solid in water to a
ﬁnal concentration of 1 mM, adjusting the pH to 10 with NaOH, and
heating at 100 C until the solution clariﬁed. Genistein (#13157-011)
and tyrphostin A25 (#13159-017) were from Gibco. Tyrphostins A1,
A8, A9, A23, A25, A47, AG1288, B42, B44, B46, B48, B50, and B56
were obtained from Calbiochem (La Jolla, CA). Microcystin-LR
(#475815) was obtained from Calbiochem. Genistein, microcystin, and
tyrphostins were dissolved in dimethyl sulfoxide (DMSO) to a con-
centration of 1 mM.
2.2. Tissue fractionation
Pcmt1+/+ and Pcmt1)/) mice with a normal or disrupted gene for
the L-isoaspartyl/D-aspartyl methyltransferase were generated in a
strain background that is about 50% 129svJae and 50% C57BL/6 [16].
After weaning at 20 d, mice were maintained on a NIH-31 Modiﬁed
Mouse/Rat Diet #7013 on a 12 h cycle of dark and light. Kidneys,
liver, heart, brain and testes were removed and added to 8 volumes of
250 mM sucrose, 5 mM HEPES buﬀer (adjusted to pH 7.2 with Tris
base) at 0 C. Tissues were minced and homogenized with a tight-ﬁt-
ting teﬂon pestle rotating at 310 rpm for 60 s. Lysates were centrifuged
at 13 000 g for 50 min and the supernatant (at about 10 mg protein/
ml) taken for further analysis. Protein concentrations were determined
after precipitation with 10% trichloroacetic acid by the Lowry method
using a standard of bovine serum albumin.
2.3. Methylation reactions and gel electrophoresis
Tissue lysate supernatants (60 lg protein) were incubated for 60 min
at 37 C with 3 ll of 12 lM S-adenosyl-L-[methyl-3H]methionine
(Amersham Pharmacia Biotech, 70–81 Ci/mmol, in dilute HCl:ethanol
(9:1), pH 2–2.5) in 25 mM HEPES buﬀer (adjusted to pH 7.5 with Tris
base) in a ﬁnal volume of 30 ll. Sodium vanadate was added when
indicated to a ﬁnal concentration of 100 lM; tyrphostins, genistein,
and microcystin (all in DMSO) were added when indicated to ﬁnal
concentrations of 100 lM. Reactions were stopped by adding 30 ll of
SDS gel sample buﬀer (180 mM Tris/HCl, pH 6.8, 4% SDS, 0.1% b-
mercaptoethanol, 20% glycerol, and 0.002% bromphenol blue) and
heating at 100 C for 5 min. Samples were electrophoresed at 35 mA
for 5 h using either Lammeli [17] or pH 2.4 [18] buﬀer systems on a gel
prepared with 12.6% acrylamide and 0.43% N,N-methylene-bis-
acrylamide (1.5 mm thick, 10.5 cm resolving gel, 2 cm stacking gel).
Gels were stained with Coomassie Brilliant Blue R-250 for 30 min and
destained in 10% methanol, 5% acetic acid overnight. For ﬂuorogra-
phy, gels were treated with EN3HANCE (Perkin–Elmer Life Sciences).
Gels were dried at 70 C in vacuo and exposed to Kodak X-Omat AR
scientiﬁc imaging ﬁlm at )80 C.
2.4. Amino acid analysis of methylation reactions
Protein precipitates of reaction mixtures incubated in 12.5% tri-
chloroacetic acid, or the portion of a stained SDS gel lane corre-
sponding to the 15-kDa region diced into small pieces, were placed in a
6 50-mm glass vial with 100 ll of 6 N HCl. Acid hydrolysis was then
carried out in a Waters Pico-Tag vapor-phase apparatus in vacuo for
20 h at 110 C. Residual acid was removed by vacuum centrifugation
and the resulting hydrolyzed material was resuspended in 50 ll of
water and mixed with 1.0 lmol of each of the standards x-NG-mo-
nomethylarginine (Sigma product M7033; acetate salt) asymmetric x-
NG, NG-dimethylarginine (Sigma product D4268; hydrochloride) and
N e;N e;N e-trimethyllysine (Sigma product T1660) for amino acid
analysis by column chromatography. Citrate dilution buﬀer (500 ll;
0.2 M Naþ, pH 2.2) was added to the hydrolyzed samples before
loading onto a cation-exchange column (Beckman AA-15 sulfonated
polystyrene beads; 0.9-cm inner diameter 7-cm column height)
equilibrated and eluted with sodium citrate buﬀer (0.35 M Naþ, pH5.27) at 1 ml/min at 55 C. One min fractions were collected and 200 ll
aliquots of every other fraction were added to 400 ll of water in 5 ml of
scintillation ﬂuor (Safety Solve; Research Products International) and
counted. The standards were analyzed using a ninhydrin assay [19].
Under our conditions, the approximate elution times were 37 min for
mono, di, and trimethyllysine, 45 min for 1- and 3-methylhistidine, 50
min for methylamine, 65 min for asymmetric dimethylarginine, 70 min
for symmetric dimethylarginine, and 76 min for monomethylarginine
[19].
2.5. Chemical analyses of protein [3H]methyl group linkages
After gel electrophoresis of a methylation reaction as described
above, the 15-kDa region of a lane was sliced out of the wet stained gel
and placed in the bottom of a 1.5 ml microcentrifuge tube as previously
described [20]. Either 0.2 ml of 2 M Na2CO3 or 0.2 ml of 2 M NaOH
was added to the tube, which was then placed in a 20 ml scintillation
vial containing 5 ml of ﬂuor (Safety Solve) and incubated at 37 C for
24 h to allow any [3H]methanol formed by alkaline hydrolysis of
methyl esters or [3H]methyl amines formed by the alkaline breakdown
of methylated arginine residues to diﬀuse into the scintillation ﬂuid.
The vials were then counted. To determine the total radioactivity in the
sample, the vials were shaken to mix the complete contents of the
microcentrifuge tube with the scintillation ﬂuor and counted again.
Gel slices containing the 15-kDa region were also analyzed for
[3H]methanol formation after digestion with proteolytic enzymes as
previously described [10]. Brieﬂy, gel slices were immersed in 250 ll of
either 1 lg/ml trypsin (Sigma, Type IX, bovine pancreas), 1 lg/ml
chymotrypsin (Sigma, type II, bovine pancreas), or 50 lg/ml car-
boxypeptidase Y (Sigma, from Saccharomyces cerevisiae) in a solution
of 0.2 M Tris, 0.1 M citrate, pH 6.0, and 1% Triton X-100 in a 1.5 ml
microcentrifuge tube. The microcentrifuge tube was placed in a 20 ml
scintillation vial containing 5 ml ﬂuor as described above and incu-
bated for 24 h at 37 C for trypsin or at 30 C for chymotrypsin and
carboxypeptidase Y. The vials were then counted for radioactivity that
diﬀused into the scintillation ﬂuor.3. Results and discussion
It has been previously shown that addition of a tyrphostin
tyrosine kinase inhibitor to rat kidney cytosolic extracts in the
presence of S-adenosyl-[methyl-3H]-L-methionine ([3H]Ado-
Met) causes a large increase in the [3H]methylation of several
species fractionated on SDS gels [13]. We conﬁrmed this ob-
servation in mouse kidney soluble extracts with tyrphostin A25
and demonstrated that its stimulatory eﬀect requires the
presence of the protein phosphatase inhibitor vanadate
(Fig. 1). The eﬀect appears to be at least partially speciﬁc,
because the tyrosine kinase inhibitor genistein, in the presence
or absence of vanadate, has no eﬀect. We show that species
migrating as polypeptides of 64 and 42 kDa are more highly
methylated and that species of 40, 36, 31, and 15 kDa are
apparently methylated de novo in the presence of tyrphostin
A25 and vanadate (Fig. 1). The most dramatic change is in the
methylation of the 15-kDa species. We also observed an in-
hibition with tyrphostin and vanadate of the methylation of
20- and 34-kDa species, perhaps as a result of competition for
[3H]AdoMet. When DMSO, the solvent for tyrphostin and
genistein, was added by itself, the only change observed was
the loss of methylation of a minor 23-kDa protein (Fig. 1).
It was initially hypothesized that tyrphostin stabilizes the
methylated substrates of the L-isoaspartyl/D-aspartyl methyl-
transferase [13]. To test this hypothesis, we performed two
experiments. In the ﬁrst place, we tested the eﬀect of tyrphostin
and vanadate, alone and in combination, on the rate of de-
methylation of [3H]methylated species from the protein frac-
tion of tyrphostin and vanadate-treated kidney extracts. We
found no signiﬁcant demethylation up to 180 min of incuba-
Fig. 1. Tyrphostin A25 and vanadate stimulate the [3H]AdoMet-de-
pendent methylation of polypeptides in mouse kidney soluble extracts.
Methylation reactions were performed as described in Section 2 in the
presence or absence of 10% DMSO, 100 lM sodium vanadate, 100 lM
genistein/10% DMSO, and 100 lM tyrphostin A25/10% DMSO.
Polypeptides were fractionated by SDS gel electrophoresis as described
in Section 2 and radiolabeled species visualized after gels were exposed
to ﬁlm for 2 months. The position of marker proteins (Bio-Rad low
molecular weight standards) electrophoresed in a parallel lane is shown
by the lines on the left (rabbit muscle phosphorylase, 97.4 kDa; bovine
serum albumin, 66.2 kDa; hen egg ovalbumin, 42.7 kDa; bovine car-
bonic anhydrase, 31 kDa; soybean trypsin inhibitor, 21.5 kDa; and hen
egg lysozyme, 14.0 kDa). Polypeptides whose methylation is increased
upon the addition of tyrphostin and vanadate are indicated by an
asterisk on the right of the gel, while polypeptides whose methylation is
nearly completely dependent upon tyrphostin and vanadate addition
are marked by a double asterisk.
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that the eﬀect of these compounds was not dependent upon the
inhibition of a demethylase or direct binding and stabilization
of the protein methyl groups. In the second place, we analyzed
methylation in extracts of kidneys from wild type mice andFig. 2. Protein methylation stimulated by tyrphostin A25 and vanadate is n
transferase. Extracts were prepared from kidney of either Pcmt1+/+ wild t
enzyme activity. Methylation reactions were performed in the presence or abs
analyzed either with a Lammeli gel (panel A on left) or a pH 2.4 gel (panel
months. The position of marker proteins is given on the left side of each pamice that had the gene encoding the L-isoaspartyl/D-aspartyl
methyltransferase disrupted [16]. The kidneys of each mouse
were homogenized and the soluble extracts were incubated
with [3H]AdoMet in the presence or absence of vanadate and
tyrphostin A25. Reaction mixtures were then analyzed by
electrophoresis on either a Lammeli SDS gel at pH 8.5
(Fig. 2A) or on a pH 2.4 gel designed to preserve labile methyl
ester linkages (Fig. 2B). We observe the same changes in
methylation upon addition of tyrphostin and vanadate with
kidney extracts lacking the L-isoaspartyl/D-aspartyl methyl-
transferase when fractionated on either the Lammeli or pH 2.4
gel system. These results suggest that this enzyme, although
responsible for the methylation of a wide variety of proteins in
eucaryotic cells, is not involved in the tyrphostin and vana-
date-stimulated methylation of the 64-, 42-, 40-, 36-, 31- or 15-
kDa species.
In light of the possible co-migration of RNA species with
polypeptides on SDS gels [21], we then asked if the species
whose methylation is stimulated with tyrphostin and vanadate
are indeed polypeptides. When RNaseA was added to reaction
mixtures, we found no change in the methylation pattern
(Fig. 3). However, when proteinase K was added, all of the
methylated species disappeared from the gel (Fig. 3). These
results conﬁrm that the tyrphostin and vanadate-stimulated
reactions involve protein methylation.
Another major class of eucaryotic methylation reactions
involves the modiﬁcation of the nitrogen atoms in the basic
amino acid residues histidine, lysine and arginine [1]. To ask
whether the tyrphostin and vanadate-stimulated reactions oc-
curred at these sites, kidney soluble extracts were incubated
with [3H]AdoMet and the acid hydrolysis products of the
protein fraction were analyzed by high-resolution cation-ex-
change chromatography (Fig. 4). We observed no stimulation
in radiolabeled peaks corresponding to the expected elution
positions of mono-, di-, and trimethyllysine, 1- and 3-meth-
ylhistidine, NG-monomethylarginine, NG;NG-dimethylargi-
nine, or NG;NG
0
-dimethylarginine. In fact, we observed
decreased methylation in several of these peaks (Fig. 4). We
also directly analyzed the major 15-kDa methylated speciesot dependent upon the activity of the L-isoaspartyl/D-aspartyl methyl-
ype mice containing the enzyme or Pcmt1)/) knockout mice lacking
ence of tyrphostin and vanadate as described in the legend to Fig. 1 and
B on right) as described in Section 2. Gels were exposed to ﬁlm for 2
nel and asterisks are used to identify stimulated proteins as in Fig. 1.
Fig. 3. Tyrphostin and vanadate stimulate protein and not RNA
methylation reactions. Methylation of kidney extracts was done as
described in Section 2 in the presence of 100 lM tyrphostin A25 and
100 lM sodium vanadate. Either 5 lg of RNaseA (bovine pancreas,
Sigma #R6513) or 10 lg of proteinase K (Tritirachium album, Sigma
#P2308) was added to the reaction mixture and the incubation con-
tinued for 30 min at room temperature for the RNaseA or overnight
for proteinase K. Reactions were then analyzed as described in Fig. 1.
The gel was exposed to ﬁlm for 23 days. The position of molecular
weight markers is shown on the left with horizontal lines and methy-
lated polypeptides are identiﬁed by asterisks on the right as in Fig. 1.
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matography as shown in Fig. 4. Here, we found no radioac-
tivity in any of the lysine, histidine, or arginine derivatives
(data not shown). Additionally, we found no radioactivity in
the 50 min position of methylamine, the expected hydrolysis
product of side chain glutamine methylation.
The results described above suggested that tyrphostin and
vanadate might stimulate a protein carboxyl methylation re-
action distinct from that catalyzed by the L-isoaspartyl/D-
aspartyl methyltransferase. This type of modiﬁcation can be
identiﬁed by treating [3H]methylated proteins with base and
analyzing for the presence of the volatile [3H]methanol prod-Control
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Fig. 4. Amino acid analysis of 3H-methylated proteins in mouse kidney extrac
or absence of 100 lM vanadate and 100 lM tyrphostin A25/10% DMSO as d
were acid hydrolyzed and chromatographed by high resolution cation exchauct. Here, we treated gel slices containing the 15-kDa
[3H]methylated protein from kidney extracts with either
Na2CO3 or NaOH. Upon treatment with NaOH, we found
that at least 62% of the total radioactivity was volatile and
could be accounted for as [3H]methanol. When the gel slice
was treated with Na2CO3, at least 80% of the total radioac-
tivity was volatile (data not shown). These results suggest that
the tyrphostin and vanadate-stimulated methylation involves
the formation of methyl ester linkages.
To determine whether this methylation may be occurring
at the C-terminal alpha-carboxyl group, we treated the la-
beled 15-kDa species with enzymes that can cleave a methyl
ester linkage at this position [10]. However, we found no
production of volatile radioactivity as [3H]methanol upon
treatment with chymotrypsin, trypsin, and carboxypeptidase
Y (data not shown). These enzymes would be expected to
liberate [3H]methanol from the methylated C-terminal leu-
cine residue of protein phosphatase 2A [10], the methylated
lysine residue of elongation factor 1A [10], and isoprenylated
cysteine residues of various species [22], respectively. We also
chromatographed the carboxypeptidase Y digestion products
on cation exchange chromatography as described [23] and
found no evidence for the presence of either aspartate or
glutamate side chain methyl esteriﬁcation (data not shown).
These results suggest that the tyrphostin and vanadate-
stimulated methylation is a novel type of protein carboxyl
methylation reaction.
We next tested to see if tyrphostin A25 and vanadate could
stimulate methylation in other mouse tissues. Heart, brain, and
testis lysates were incubated with [3H]AdoMet in the presence
or absence of vanadate and tyrphostin (Fig. 5). In heart
extracts, tyrphostin with or without vanadate stimulated the
methylation of 64-, 42-, 40-, 36-, 31-, 18- and 15-kDa poly-
peptides. Except for the 18-kDa species, methylation of all of
these polypeptides were also observed to be stimulated in
kidney extracts. In brain extracts, we observed only a slight
stimulation of a 24.4-kDa polypeptide with tyrphostin, and the
combination of tyrphostin and vanadate actually caused a
general inhibition of the basal methylation levels. Finally, in
testis, there was little change in the methylation pattern in the
presence or absence of tyrphostin and vanadate. These results+Tyrphostin A25 and Vanadate
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ts. Methylation of soluble tissue extracts was performed in the presence
escribed in Fig. 1. After precipitation with trichloroacetic acid, proteins
nge chromatography as described in Section 2.
Fig. 5. Tyrphostin A25 and vanadate aﬀect methylation of polypeptides in extracts of mouse heart, brain, and testis. Methylation of soluble tissue
extracts was performed in the presence or absence of 100 lM vanadate and 100 lM tyrphostin A25/10% DMSO as described in Fig. 1. Gels were
exposed to ﬁlm for 33 days. The position of molecular weight markers is shown with horizontal lines and of that of the stimulated methylated
polypeptides by asterisks.
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system is active in both kidney and heart with the increased
methylation of at least some similarly sized polypeptides. On
the other hand, this pathway does not appear to operate in
testes and may be limited to a 24.4 kDa species in brain. We
also tested to see if tyrphostin and vanadate had an eﬀect on
methylation of extracts of the yeast Saccharomyces cerevisiae.
Neither tyrphostin nor vanadate had any eﬀect when added
alone, and when both compounds were added to the reaction
we saw a decrease in methylation (data not shown).
We then asked if the increase in methylation seen by the
addition of tyrphostin was speciﬁc to tyrphostin A25 or if
other tyrphostins also had the same eﬀect on methylation
(Table 1). Tyrphostins A1, A8, A9, A23, A25, A47, AG1288,
B42, B44, B46, B48, B50, and B56 [14,15] were incubated with
kidney cytosol with and without vanadate along withTable 1
The eﬀect of tyrphostin A25 derivatives on the methylation of kidney
cytosolic proteinsa
Tyrphostin AG# IC50 (lM)b Eﬀect on stimulation
of methylation
A1 AG 9 >1250 )
A8 AG 10 560 )
A9 AG 17 460 )
A23 AG 18 35 )
A25 AG 82 3 +++
A47 AG 213 2.4 ++
AG 1288 )
B42 AG 490 2 )
B44 AG 527 0.4 )
B46 AG 555 0.7 )
B48 AG 494 0.7 )
B50 AG 835 0.86 )
B56 AG 556 1.1 )
aMethylation of kidney extracts was performed with 100 lM of the
indicated tyrphostin and 100 lM vanadate as described in Section 2.
b IC50 values for the inhibition of the phosphorylation of polyGAT by
EGFRK [22,23].[3H]AdoMet. With the exception of tyrphostin A47, we found
that none of the other tyrphostins had any eﬀect on the
methylation of the endogenous kidney cytosolic proteins. Since
many of these tyrphostin species inhibit the epidermal growth
factor receptor kinase activity nearly equally as well as A25
(Table 1) and because many of the inactive compounds are
either broad spectrum inhibitors of protein tyrosine kinases
[24–26] or are active on other types of these enzymes [27,28],
the stimulation of methylation with A25 and A47 may be due
to its interaction with a distinct type of protein. Alternatively,
A25 and A47 may be speciﬁc for a yet undescribed class
of protein tyrosine kinases, or perhaps a distinct class of
molecules.
Sodium vanadate is a known protein tyrosine phosphatase
inhibitor but also has additional eﬀects on a number of other
types of hydrolytic enzymes, including the Naþ/Kþ ATPase
and small molecule phosphatases [29]. To ask if the eﬀect of
vanadate might be mimicked by a distinct type of protein
phosphatase inhibitor, we substituted microcystin-LR for
vanadate (Fig. 6). We found, however, that it showed no
stimulation of methylation in kidney extracts incubated with
tyrphostin. This result suggests some speciﬁcity to the action of
vanadate. It is possible, in fact, that vanadate acts at a site or
sites distinct from those of protein phosphatases. Further work
will be needed to establish the molecular basis of the vanadate,
as well as the tyrphostin, eﬀects.
The nature of the enzyme or enzymes that catalyze the tyr-
phostin/vanadate-stimulated protein carboxyl methylation
observed here is unknown. However, if the eﬀects of tyrphostin
and vanadate are due to their interactions with protein kinases
and phosphatases, then this system may well represent an
additional example where there are linkages between protein
phosphorylation reactions involved in cellular signaling and
protein methylation reactions. For example, the activity of
protein arginine methyltransferase 1 is stimulated by the NGF
tyrosine kinase [30] and participates in the signaling cascade
of phosphorylated forms of the STAT1 protein [31]. Protein
Fig. 6. The eﬀect of microcystin-LR on the methylation of kidney
soluble proteins. Methylation of kidney extract proteins was per-
formed in the presence or absence of 100 lM tyrphostin A25/10%
DMSO, 100 lM vanadate (V) and 100 lM microcystin-LR/10%
DMSO (M) as described in Section 2. The gel was exposed to ﬁlm for 2
months. The position of molecular weight markers is shown on the left
with horizontal lines and of enhanced methylated polypeptides by
asterisks on the right as in Fig. 1.
186 T.B. Miranda et al. / FEBS Letters 577 (2004) 181–186arginine methyltransferase 5 binds speciﬁcally to the JAK2
kinase [19,32]. The major protein phosphatase 2A is regulated
by reversible carboxyl methylation [3,4,6] and the cheB
methylesterase of bacterial chemotaxis is itself regulated by
phosphorylation [5]. Several tyrosine kinase inhibitors are
presently in clinical trials as anti-tumor drugs [33] and it would
be interesting to see if any of these agents also stimulate pro-
tein carboxyl methylation reactions. The situation is complex
because both the stimulatory eﬀects of tyrphostin and vana-
date would seemingly involve both the inhibition and stimu-
lation of protein phosphorylation; multiple enzymes may be
involved here, or the sites of action of these compounds may in
fact be distinct from enzymes involved in reversible protein
phosphorylation reactions.
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